ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Vitamin D supplementation extends life in mouse model of Huntington's disease

Omega-3 fatty acid stops known trigger of lupus

Conquer Your Email Inbox, Increase Productivity and Reduce Stress

The Significance of Selenium

Print Page
Email Article

Study Identifies Alzheimer's Associated Changes in the Eye

  [ 78 votes ]   [ Discuss This Article ] • April 14, 2003

A research team led by investigators from Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) has discovered that amyloid-beta (A-beta), the protein that forms plaques in the brains of people with Alzheimer's disease, can also be detected in the lens of the human eye. The investigators were able to identify A-beta in lens samples from elderly individuals with and without the disorder; however, an unusual pattern of amyloid deposits was found only on the lenses of Alzheimer's patients.

The observation, published in the April 12 issue of The Lancet, could lead to the development of a non-invasive test to diagnose and track the development of the devastating brain disorder. Eventually, such a test might be used to measure the effectiveness of new strategies to treat or prevent Alzheimer's symptoms and to diagnose the disease in its earliest stages, when new treatments are likely to be most effective. The researchers are planning further studies to confirm their discoveries.

"The formation of A-beta plaques in the brain and the development of cataracts in the lens are both examples of accumulated protein associated with age-related degenerative damage," says Lee Goldstein, MD, PhD, the paper's lead author and a member of the MGH Genetics and Aging Research Unit. "In addition, people with Down's Syndrome, who develop Alzheimer's at an early age, are also prone to early-onset cataracts. But as far as we know, no one had investigated whether there might be any association between the pathology of Alzheimer's disease and age-related changes in the lens."

Goldstein also is associate director for Basic Research at the Center for Ophthalmic Research of the BWH Department of Surgery, a member of the psychiatry departments at MGH and BWH and the MGH Laboratory for Oxidation Biology, and assistant professor of Psychiatry at Harvard Medical School (HMS).

The researchers examined samples of brain tissue and lenses taken from nine people who had died with Alzheimer's disease and from eight controls who died with other neurodegenerative disorders. They also tested samples of aqueous humor (the fluid within the chamber at the front of the eye) taken from healthy volunteer patients who were having cataracts removed.

A-beta was found in all of the lenses studied in concentrations similar to that found in brain tissue samples. It also was detected in the aqueous humor samples at levels comparable to those typically seen in cerebrospinal fluid. Although differences in tissue concentrations of A-beta between the Alzheimer's and non-Alzheimer's samples have not yet been determined, the researchers found a distinctive pattern of A-beta deposits in the outer, peripheral portion of only the lenses from Alzheimer's patients.

"One of the most exciting aspects of this finding is the fact that these deposits are associated with a type of cataract seen rarely in the general population," says Leo T. Chylack, Jr., MD, Director of the BWH Center for Ophthalmic Research and one of the study's principal investigators. "These cataracts do not block vision and can only be seen when the pupil is dilated widely, so they previously would not have been detected in Alzheimer's patients. If the association of these deposits with Alzheimer's holds up in future studies, it would be very simple to develop a non-invasive test of disease progression." Dr. Chylack is professor and vice-chairman (research) of Ophthalmology at HMS.

The researchers note that while many potential treatments for Alzheimer's are under development, testing and effectively using such therapies would require a way to accurately diagnose and monitor the disease, something that does not currently exist.

"Development, testing and effective implementation of any new anti-Alzheimer's therapy requires a safe and effective means of diagnosing and monitoring disease progress," says Goldstein. "If patients at risk of developing the disease could be identified early and accurately, ideally before cognitive symptoms emerge, therapeutic interventions can be instituted before the onset of irreparable damage to the brain.

"Because the lens does not clear protein deposits in the way that brain tissue does, there is a good possibility that a non-invasive test could be developed to identify these deposits in a sensitive and quantitative manner," he adds. An intensive project to develop such a test is underway.

Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® FibroSleep™ Energy NADH™ 12.5mg

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
Quercetin: Natural Support for Allergy & Inflammation Relief and More Quercetin: Natural Support for Allergy & Inflammation Relief and More
Physically and Mentally Exhausted? How to Restore Energy at Its Source Physically and Mentally Exhausted? How to Restore Energy at Its Source
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map